Cybin Inc (CYBN) Stock Analysis

Cybin Inc (CYBN) is a publicly traded company in the HEALTHCARE sector. It trades at $8.28. This page summarizes the public market data, fundamentals, and frequently asked questions for CYBN, with GNG Research's proprietary safety, quality, and valuation analysis available to members.

Sector: HEALTHCARE - BIOTECHNOLOGY

Exchange: NYSE MKT

Key Metrics

• Price: $8.28

Market Sentiment

Cybin Inc currently has a Neutral sentiment score of 0.07.

About Cybin Inc

None

GNG Research Analysis

GNG Research scores Cybin Inc (CYBN) on three proprietary dimensions — a Safety score, a Quality score, and a Valuation score — alongside fair value estimates and buy-price targets for 5,000+ companies. These ratings are reserved for members. Read how the scores are calculated on our methodology page, or see GNG Research plans to unlock the full rating for CYBN.

Frequently Asked Questions

Does CYBN pay dividends?

Cybin Inc (CYBN) does not currently pay a regular dividend.